https://accanitotx.com/2026-04-01T17:16:59+00:00https://accanitotx.com/contact-us/2026-04-02T19:27:36+00:00https://accanitotx.com/about-company/2026-04-04T09:06:05+00:00https://accanitotx.com/our-team/2026-04-07T18:42:22+00:00https://accanitotx.com/gam-05/2026-04-14T00:38:17+00:00https://accanitotx.com/investors/2026-04-14T01:38:04+00:00https://accanitotx.com/latest-news/2026-04-14T01:32:32+00:00https://accanitotx.com/mechanism-of-action-differentiation/2026-04-14T01:01:14+00:00https://accanitotx.com/validation-of-selective-target-engagement/2026-04-14T00:35:33+00:00https://accanitotx.com/mitochondrial-dysfunction-cell-death-induction/2026-04-14T01:07:48+00:00https://accanitotx.com/preclinical-efficacy-translational-readiness/2026-04-14T01:13:18+00:00https://accanitotx.com/adme-toxicology-phase-i-enabling/2026-04-14T01:19:29+00:00https://accanitotx.com/phase-i-clinical-strategy-value-oriented-design/2026-04-14T01:26:23+00:00